Page last updated: 2024-08-17

acetyl coenzyme a and Lymphoma, T-Cell

acetyl coenzyme a has been researched along with Lymphoma, T-Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Brenner, D; Cernilogar, FM; Choi, J; Choi, S; Daniels, J; Forne, I; Gabler, JV; Giustinani, J; Guitart, J; Hameister, E; Hundshammer, C; Imhof, A; Jain, S; Joshi, A; Klement, C; Konstantinidis, F; Kurniawan, H; Law, C; Lee, Y; Morrish, E; Müschen, M; Ortonne, N; Park, J; Rad, R; Ruland, J; Schilling, F; Schneider, H; Schotta, G; Schulz, M; van Heijster, FHA; Venkatasubramani, AV; Wartewig, T; Weinstock, DM1

Other Studies

1 other study(ies) available for acetyl coenzyme a and Lymphoma, T-Cell

ArticleYear
PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma.
    Nature cancer, 2023, Volume: 4, Issue:10

    Topics: Acetyl Coenzyme A; Animals; Genes, Tumor Suppressor; Glycolysis; Humans; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Mice; Programmed Cell Death 1 Receptor; Transcription Factor AP-1

2023